Immunohistochemical Study Protocol in Thyroid Pathology.

Area of Science:

• Oncology
• Pathology
• Immunohistochemistry

Background:

• Immunohistochemistry is crucial for diagnosing neoplastic pathology.
• It differentiates tumor origins, e.g., follicular vs. C-cell tumors using specific markers.
• Classifying thyroid carcinomas often requires immunohistochemical analysis.

Purpose of the Study:

• To evaluate the utility of immunohistochemical studies in diagnosing thyroid neoplastic pathology.
• To highlight the role of specific markers in differentiating tumor origins and types.
• To assess the effectiveness of antibody panels in classifying thyroid carcinomas.

Main Methods:

• Utilizing specific antibodies like thyroglobulin, TTF1, calcitonin, and neuroendocrine markers.
• Employing antibody panels including HMBE1, galectin 3, and CK19.
• Applying automated protocols for differential diagnosis based on histological morphology.

Main Results:

• Thyroglobulin and TTF1 identify follicular origin tumors; calcitonin and neuroendocrine markers identify C-cell tumors.
• HMBE1 and galectin 3 assist in distinguishing malignancy from benignity.
• CK19, galectin 3, and HMBE1 aid in identifying papillary carcinomas of the follicular variant.

Conclusions:

• Immunohistochemical studies are invaluable for diagnosing and classifying thyroid neoplastic pathology.
• Specific markers and antibody panels are essential for accurate tumor origin determination and malignancy assessment.
• Automated immunohistochemical protocols enhance diagnostic accuracy in complex thyroid carcinoma cases.